DNMT1 and lip and oral cavity carcinoma: Of the 125 oral cancer tissues assayed for DNMT3b and DNMT1 using IHC analysis, 76 (61%) gave DNMT3b positive immunoreactivity but only 36% (45/125) with DNMT1 positive staining.